307 related articles for article (PubMed ID: 32599662)
1. Ethnic and socio-economic disparities in prostate cancer screening: lessons from New Zealand.
Matti B; Lyndon M; Zargar-Shoshtari K
BJU Int; 2021 Dec; 128 Suppl 3():11-17. PubMed ID: 32599662
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand.
Obertová Z; Scott N; Brown C; Hodgson F; Stewart A; Holmes M; Lawrenson R
BMC Fam Pract; 2014 Aug; 15():145. PubMed ID: 25154420
[TBL] [Abstract][Full Text] [Related]
3. Do Maori and Pacific Islander men present with more advanced prostate cancer than European New Zealand men? An analysis of 486 men undergoing biopsy in Auckland.
Pokorny MR; Scott DJ
BJU Int; 2011 Apr; 107 Suppl 3():27-32. PubMed ID: 21492373
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum prostate-specific antigen levels and public health implications in three New Zealand ethnic groups: European, Maori, and Pacific Island men.
Gray M; Borman B; Crampton P; Weinstein P; Wright C; Nacey J
N Z Med J; 2005 Feb; 118(1209):U1295. PubMed ID: 15711628
[TBL] [Abstract][Full Text] [Related]
5. Inequalities between Māori and non-Māori men with prostate cancer in Aotearoa New Zealand.
Egan R; Lawrenson R; Kidd J; Cassim S; Black S; Blundell R; Bateman J; Broughton JR
N Z Med J; 2020 Sep; 133(1521):69-76. PubMed ID: 32994638
[TBL] [Abstract][Full Text] [Related]
6. Survival disparities between Māori and non-Māori men with prostate cancer in New Zealand.
Obertová Z; Scott N; Brown C; Stewart A; Lawrenson R
BJU Int; 2015 Apr; 115 Suppl 5():24-30. PubMed ID: 25124231
[TBL] [Abstract][Full Text] [Related]
7. Improving survival disparities in cervical cancer between Māori and non-Māori women in New Zealand: a national retrospective cohort study.
McLeod M; Harris R; Purdie G; Cormack D; Robson B; Sykes P; Crengle S; Iupati D; Walker N
Aust N Z J Public Health; 2010 Apr; 34(2):193-9. PubMed ID: 23331365
[TBL] [Abstract][Full Text] [Related]
8. Treatment modalities for Māori and New Zealand European men with localised prostate cancer.
Obertová Z; Lawrenson R; Scott N; Holmes M; Brown C; Lao C; Tyrie L; Gilling P
Int J Clin Oncol; 2015 Aug; 20(4):814-20. PubMed ID: 25557325
[TBL] [Abstract][Full Text] [Related]
9. Rural-Urban Differences in Prostate-Specific Antigen (PSA) Screening and Its Outcomes in New Zealand.
Obertová Z; Hodgson F; Scott-Jones J; Brown C; Lawrenson R
J Rural Health; 2016; 32(1):56-62. PubMed ID: 26174590
[TBL] [Abstract][Full Text] [Related]
10. The effect of Māori ethnicity misclassification on cervical screening coverage.
Sandiford P; Salvetto M; Bramley D; Wong S; Johnson L
N Z Med J; 2013 Apr; 126(1372):55-65. PubMed ID: 23793178
[TBL] [Abstract][Full Text] [Related]
11. Ethnic differences in acute hospitalisations for otitis media and elective hospitalisations for ventilation tubes in New Zealand children aged 0-14 years.
McCallum J; Craig L; Whittaker I; Baxter J
N Z Med J; 2015 Jun; 128(1416):10-20. PubMed ID: 26117671
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic prostate cancer screening: A population-based analysis.
Matti B; Zargar-Shoshtari K
Urol Oncol; 2020 May; 38(5):393-400. PubMed ID: 31952998
[TBL] [Abstract][Full Text] [Related]
13. The costs of identifying undiagnosed prostate cancer in asymptomatic men in New Zealand general practice.
Lao C; Brown C; Obertová Z; Edlin R; Rouse P; Hodgson F; Holmes M; Gilling P; Lawrenson R
Fam Pract; 2013 Dec; 30(6):641-7. PubMed ID: 24055993
[TBL] [Abstract][Full Text] [Related]
14. Environmental exposure to trace elements and prostate cancer in three New Zealand ethnic groups.
Gray MA; Centeno JA; Slaney DP; Ejnik JW; Todorov T; Nacey JN
Int J Environ Res Public Health; 2005 Dec; 2(3-4):374-84. PubMed ID: 16819092
[TBL] [Abstract][Full Text] [Related]
15. Changing trends in indigenous inequalities in mortality: lessons from New Zealand.
Tobias M; Blakely T; Matheson D; Rasanathan K; Atkinson J
Int J Epidemiol; 2009 Dec; 38(6):1711-22. PubMed ID: 19332501
[TBL] [Abstract][Full Text] [Related]
16. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.
Assel M; Dahlin A; Ulmert D; Bergh A; Stattin P; Lilja H; Vickers AJ
Eur Urol; 2018 Jun; 73(6):961-967. PubMed ID: 29066048
[TBL] [Abstract][Full Text] [Related]
17. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
[TBL] [Abstract][Full Text] [Related]
18. Ethnic differences in prostate cancer survival in New Zealand: a national study.
Sneyd MJ
Cancer Causes Control; 2008 Nov; 19(9):993-9. PubMed ID: 18478341
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer--are ethnic minorities disadvantaged?
Lamb DS; Bupha-Intr O; Bethwaite P; Murray J; Nacey J; Russell G; Delahunt B
Anticancer Res; 2008; 28(6B):3891-5. PubMed ID: 19192646
[TBL] [Abstract][Full Text] [Related]
20. Inequity in timing of prenatal screening in New Zealand: Who are our most vulnerable?
Payne O; Pillai A; Wise M; Stone P
Aust N Z J Obstet Gynaecol; 2017 Dec; 57(6):609-616. PubMed ID: 28617944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
